Mena Abdel-Nour, MSc, PhD
Vice President, Investment Banking
Mena Abdel-Nour is Vice President, Investment Banking, he joined Bloom Burton as an Analyst in 2019. In this role, Mena seeks out innovative life science companies and leads search and evaluation of biotechnology companies outside Canada for financing prospects.
As part of the Strategic Advisory team, Mena performs asset search mandates and out-licensing / partnership solicitation work for a broad range of life sciences companies, including early-stage biotechs and large pharmaceutical companies. Mena is also the fractional business development manager at Appili Therapeutics, a Bloom Burton incubated infectious disease biotechnology company. He identifies novel opportunities within the infectious disease and medical countermeasures space to broaden Appili’s portfolio and establish partnerships for the company’s pipeline programs.
On a monthly basis, Mena publishes Canada in Science, a monthly blog highlighting high quality biomedical research from different institutions across the country.
Prior to joining Bloom Burton, Mena has pursued the commercialization and development of novel therapeutics for inflammatory disease based on his research published in the journal, Science, and has supported entrepreneurial healthcare opportunities through the Translational Research Program at the University of Toronto. Mena completed his PhD at the University of Toronto where he focused on the biochemistry and molecular biology of innate immunology. His MSc was completed in collaboration with Public Health Ontario studying the biofilm formation of Legionella pneumophila.
Mena Abdel-Nour is Vice President, Investment Banking, he joined Bloom Burton as an Analyst in 2019. In this role, Mena seeks out innovative life science companies and leads search and evaluation of biotechnology companies outside Canada for financing prospects.
